A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib.

Saved in:
Bibliographic Details
Title: A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib.
Authors: Wang, Huaxiang1 (AUTHOR) whx19930307@163.com, Li, Junjun2 (AUTHOR), Zhu, Xiuling3 (AUTHOR), Wang, Ruling1 (AUTHOR), Wan, Yunyan1 (AUTHOR) docwan@163.com
Source: Scientific Reports. 1/9/2025, Vol. 15 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-85831-4